This announcement is a separate document:
開拓藥業-B：自願公告 福瑞他恩治療男性雄激素性脫髮關鍵性臨床試驗獲中國NMPA同意開展
KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT PIVOTAL STUDY OF PYRILUTAMIDE FOR TREATMENT OF ANDROGENETIC ALOPECIA MALE PATIENTS RECEIVED CLEARANCE BY CHINA NMPA
Nov 24, 2021 22:42
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.